Select Publications
Book Chapters
2023, 'Regulatory Landscape in Australia and New Zealand', in Handbook of Cell and Gene Therapy: From Proof-of-Concept through Manufacturing to Commercialization, pp. 233 - 242, http://dx.doi.org/10.1201/9781003285069-15
,2023, 'Training Approaches to Build Cell and Gene Therapy Workforce Capacity', in Handbook of Cell and Gene Therapy: From Proof-of-Concept through Manufacturing to Commercialization, pp. 175 - 182, http://dx.doi.org/10.1201/9781003285069-10
,2021, 'Authorization Procedures for Pharmaceutical Products', in Hall G (ed.), Fundamentals of International Regulatory Affairs, Regulatory Affairs Professionals Society, USA, pp. 187 - 206, https://my.raps.org/online-store/merchandise-details/?id=0eeaf613-5fd3-eb11-ba5e-0003ff45124f&reload=timezone
,2018, 'Authorization Procedures for Pharmaceutical Products', in Jones P (ed.), Fundamentals of International Regulatory Affairs, Regulatory Affairs Professional Society, USA, pp. 91 - 108
,2017, 'Authorisation procedures for pharmaceutical products', in Jones P (ed.), Fundamentals of international regulatory affairs, RAPS, MD, USA, pp. 69 - 80, https://www.raps.org/ProductDetail.aspx?ProductId=131091030
,Journal articles
2024, 'Building a Competency Framework to Integrate Inter-disciplinary Precision Medicine Capabilities into the Medical Technology and Pharmaceutical Industry', Therapeutic Innovation and Regulatory Science, 58, pp. 567 - 577, http://dx.doi.org/10.1007/s43441-024-00626-5
,2023, 'A Survey of Industry Perceptions of Facilitated Regulatory Pathways in Drug Development in Australia', Pharmaceutical Medicine, 37, pp. 385 - 394, http://dx.doi.org/10.1007/s40290-023-00483-x
,2023, 'Regulatory Reform Outcomes and Accelerated Regulatory Pathways for New Prescription Medicines in Australia', Therapeutic Innovation and Regulatory Science, 57, pp. 271 - 286, http://dx.doi.org/10.1007/s43441-022-00465-2
,2023, 'Future directions in regulatory affairs', Frontiers in Medicine, 9, http://dx.doi.org/10.3389/fmed.2022.1082384
,2022, 'Oncofertility Information Available for Recently Approved Novel Non Cytotoxic and Immunotherapy Oncology Drugs', Clinical Pharmacology and Therapeutics, 111, pp. 382 - 390, http://dx.doi.org/10.1002/cpt.2254
,2022, 'Multi-Criteria Decision Analysis for Benefit-Risk Analysis by National Regulatory Authorities', Frontiers in Medicine, 8, http://dx.doi.org/10.3389/fmed.2021.820335
,2020, 'Creeping Through the Backdoor: Disruption in Medicine and Health', Frontiers in Pharmacology, 11, http://dx.doi.org/10.3389/fphar.2020.00818
,2019, 'Australia's National Medicines Policy is outdated and in need of review', Medical Journal of Australia, 211, pp. 252 - 254, http://dx.doi.org/10.5694/mja2.50268
,2019, 'Professional Development: Benefits of Obtaining Professional Qualifications', Regulatory Focus, https://www.raps.org/news-and-articles/news-articles/2019/8/professional-development-benefits-of-obtaining-pr
,2019, 'Curriculum Transformation: From Didactic to Competency-Based Programs in Pharmaceutical Medicine', Frontiers in Pharmacology, 10, pp. 278 - 278, http://dx.doi.org/10.3389/fphar.2019.00278
,2019, 'New Zealand’s new regulatory regime for therapeutic products', Regulatory Focus, https://www.raps.org/news-and-articles/news-articles/2019/3/new-zealands-new-regulatory-regime-for-therapeuti
,2018, 'Postgraduate Education in Pharmaceutical Medicine in Australia: Evaluation and Evolution to a Global Program Over 20 Years.', Therapeutic Innovation & Regulatory Science, 53, pp. 1 - 7, http://dx.doi.org/10.1177/2168479018793129
,2017, 'Program transformation: reimagining distance education in the digital world', Research and Development in Higher Education: Curriculum Transformation, 40, pp. 61 - 72, http://www.herdsa.org.au/research-and-development-higher-education-vol-40-61
,2017, 'Improvements in Clinical Trials Information Will Improve the Reproductive Health and Fertility of Cancer Patients', Journal of Adolescent and Young Adult Oncology, 6, pp. 235 - 269, http://dx.doi.org/10.1089/jayao.2016.0084
,2015, 'Proposed changes to US therapeutic products regulation', The Source Document, pp. 7 - 9
,2013, 'ARCS Australia University Partnerships.', The Source Document, pp. 34 - 34
,2002, 'Rapid differentiation of Australian, European and American ranaviruses based on variation in major capsid protein gene sequence.', Molecular and Cellular Probes, 16, pp. 137 - 151
,2001, 'Rescue of the colony stimulating factor 1 (CSF-1)-nullizygous mouse (Csf1op/Csf1op) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis', Blood, 98, pp. 74 - 84
,2001, 'Thrombopoietin gene regulation – a review', Haematology, 6, pp. 41 - 46
,2000, 'The role of platelet ?-granular proteins in the regulation of thrombopoietin messenger RNA expression in human bone marrow stromal cells.', Blood, pp. 3094 - 3101
,1999, 'hFOG-2, a novel zinc finger protein, binds the corepressor mCtBP2 and modulates GATAmediated activation', The Journal of Biological Chemistry, pp. 23491 - 23498
,1996, 'Absence of colony stimulating factor-1 in osteopetrotic (csfmop/csfmop) mice results in male fertility defects.', Biology of Reproduction, 55, pp. 310 - 317
,1995, 'Osteopetrotic (op/op) mice deficient in macrophages have the ability to mount a normal T-cell-dependent immune response.', Cellular Immunology, 162, pp. 146 - 152
,1994, 'ALPHA-4-BETA-1 INTEGRIN EXPRESSION ON SUBSETS OF HEMATOPOIETIC STEM-CELLS', JOURNAL OF CELLULAR BIOCHEMISTRY, pp. 10 - 10, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994MV41200025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1994, 'Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse.', Development, 120, pp. 1357 - 1372
,1993, 'DOES EXPRESSION OF THE ALPHA-4-BETA-1 INTEGRIN CHANGE WITH THE PROLIFERATIVE AND DIFFERENTIATIVE CAPACITY OF MURINE PRIMITIVE HEMATOPOIETIC STEM-CELLS', JOURNAL OF LEUKOCYTE BIOLOGY, pp. 101 - 101, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993ME18500405&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1993, 'Delayed haematopoietic development in osteopetrotic (op/op) mice.', Journal of Experimental Medicine, 177, pp. 237 - 242
,1992, 'MACROPHAGE DEVELOPMENT, AND AGE-RELATED-CHANGES IN HEMATOPOIESIS, IN CSF-1 DEFICIENT OSTEOPETROTIC (OP/OP) MICE', EXPERIMENTAL HEMATOLOGY, 20, pp. 826 - 826, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1992JA73400461&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1992, 'An in vitro fibroblast model system to study myc-driven tumour progression.', International Journal of Cancer, 51, pp. 149 - 158
,1992, 'Biology and action of colony stimulating factor-1.', Journal of Cellular Biochemistry -Supplement-, 16C, pp. 57 - 57
,1992, 'Colony-stimulating factor-1 in the regulation of placental development', Journal of Cellular Biochemistry -Supplement-, 16F, pp. 75 - 75
,1992, 'Constitutive expression of exogenous myc in myelomonocytic cells: acquisition of a more transformed phenotype and inhibition of differentiation induction.', Oncogene, 7, pp. 1827 - 1836
,1991, 'Inducible transformation of fibroblasts using a metallothionein-v-myc gene construct.', Oncogene, 6, pp. 1073 - 1077
,1989, 'The use of retroviral vectors to study cell transformation and malignancy.', Transplantation Proceedings, 21, pp. 61 - 64
,1988, 'Transfection of myeloid cell lines using polybrene/DMSO', Nucleic Acids Research, 16, pp. 2352
,1985, 'Structural and antigenic properties of human parainfluenza viruses', Virus Research, 3, pp. 78 - 78, http://dx.doi.org/10.1016/0168-1702(85)90408-3
,Conference Papers
1999, 'PDGF indirectly enhanced granulopoiesis.', in BLOOD, AMER SOC HEMATOLOGY, pp. 46B - 46B, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000083790700200&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1999, 'TSP1 inhibits PEG-rHuMGDF-induced mega karyocytopoiesis via TSP/TSP receptor interaction.', in BLOOD, AMER SOC HEMATOLOGY, pp. 41A - 41A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000083790300218&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1999, 'Transcription factor and cell surface protein expression during megakaryocyte differentiation.', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, pp. 102 - 102, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000081030100250&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1999, 'The regulation of thrombopoietin mRNA expression - an in vitro and in vivo study', in Haematology Society of Australia and New Zealand - Annual Scientific Meeting, Hobart, presented at Haematology Society of Australia and New Zealand - Annual Scientific Meeting, Hobart
,Conference Posters
2016, 'What information do cancer clinical trial protocols include on the reproductive risk of treatment and oncofertility management?', Chicago USA, presented at 10th Annual Oncofertility Consortium Conference, Chicago USA, 01 November 2016 - 03 November 2016
,(ed.), 2016, 'Empowering Online Learners Using Assessment and Feedback', UNSW, presented at Towards 2025: Inspiring Learning, UNSW, 31 October 2016 - 31 October 2016
,(ed.), 2016, 'Program transformation: reimagining education in the digital world', UNSW, pp. 22 - 22, presented at Towards 2025: Inspiring Learning, UNSW, 31 October 2016 - 31 October 2016, https://teaching.unsw.edu.au/forum
,2015, 'Teaching Cancer Therapeutics in a Postgraduate Masters Program in Pharmaceutical Medicine', Hobart, Tasmania, Australia, presented at APSA-ASCEPT Joint Scientific Meeting 2015, Hobart, Tasmania, Australia, 29 November 2015 - 02 December 2015, http://www.asceptasm.com/
,(eds.), 2015, 'Blended strategies for learning about medicines development', UNSW, pp. 74 - 75, presented at UNSW Learning and Teaching Forum - Blended Learning: Past, Present and Future, UNSW, 16 October 2015 - 16 October 2015
,